ArticleClinical and translational science2024

Utilizing venous occlusion plethysmography to assess vascular effects: A study with buloxibutid, an angiotensin II type 2 receptor agonist.

Erik Rein-Hedin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.